Page 3 - Advm News Today

StockNews.com upgraded shares of Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) from a sell rating to a hold rating in a research report report published on Monday. Separately, LADENBURG THALM/SH SH started coverage on Adverum Biotechnologies in a report on Tuesday, March 7th. They set a buy rating and a $2.00 target price on the stock. […]

Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Monday. Separately, LADENBURG THALM/SH SH assumed coverage on shares of Adverum Biotechnologies in a research report on Tuesday, March 7th. They set a “buy” rating and a […]

Houston TV news has kicked off 2023 with a slew of new hires and departures shaking up broadcast lineups.

Notices have been served to the establishments to vacate or shift the materials from the establishments and warehouses.

DVM Jobs in Pakistan published on Newspaper and apply for jobs and career ads of DVM jobs 2020 on vacancy announcements on paperads.com.

Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) was upgraded by equities research analysts at Truist Financial from a “hold” rating to a “buy” rating in a report released on Thursday, MarketBeat.com reports. The firm currently has a $4.00 price target on the biotechnology company’s stock, up from their prior price target of $3.00. Truist Financial’s price […]

Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) has been given an average recommendation of “Hold” by the six analysts that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating and five have issued a hold rating on the company. The average 1 year price target among […]

Equities research analysts predict that Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) will post earnings of ($0.38) per share for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Adverum Biotechnologies’ earnings, with the lowest EPS estimate coming in at ($0.39) and the highest estimate coming in at ($0.36). Adverum Biotechnologies […]

Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) insider Setareh Seyedkazemi bought 20,000 shares of the business’s stock in a transaction on Monday, May 23rd. The shares were purchased at an average cost of $0.84 per share, for a total transaction of $16,800.00. Following the completion of the purchase, the insider now owns 20,600 shares in […]

Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) have received a consensus rating of “Hold” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and one has assigned a buy recommendation to […]